Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started
My Medicine

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Cancer Health Center

Font Size

Tumor-Melting Virus vs. Prostate Cancer

Reovirus Is Harmless -- Except to Many Kinds of Cancers
WebMD Health News
Reviewed by Laura J. Martin, MD

March 9, 2010 - A virus that destroys cancer cells but leaves normal cells unharmed works against prostate cancer, a human study shows.

The virus also blasts lymphoid, colon, ovarian, breast, pancreatic, brain, lung, head and neck, and other cancer cells.

The virus is called reovirus, and nearly everyone has been infected with it. But almost nobody notices, because at worst, the virus causes mild flu-like symptoms. But when it infects cancer cells, reovirus is a tiger.

For nearly a decade, researchers have been looking for ways to exploit reovirus as a nontoxic cancer treatment. Now a new study takes that search one step closer to reality.

Six prostate cancer patients at Canada's Tom Baker Cancer Center had the virus injected directly into their prostate tumors by Don G. Morris, MD, PhD, and colleagues. The patients then had their prostate glands removed by previously scheduled surgery.

"The beauty of the prostate study is that we gave one injection, and by three weeks later we had the entire prostate gland to look at. So we could inject the virus into a nest of tumor cells and see what it did," Morris tells WebMD.

What it did was trigger the cancer cells' self-destruct program. All around the injection site, the reovirus -- a product from Oncolytics Biotech Inc. called Reolysin -- made cancer cells go away. Normal cells were not harmed.

The downside was that the virus did not spread throughout the prostate. Cancer cells not in the immediate area of the injection were spared.

"I don't think it is a dead end. What these studies have done is give us enough ammunition to go to regulators and say, 'Here is data that prostate cancer is an attractive target for reovirus,'" Morris says. "And we have a lot of safety data showing it is safe to give intravenously."

Putting reovirus into the bloodstream would allow it to reach cancers throughout the body, not just at the site of injection. But there's a big hurdle to overcome: After the first injection, the body mounts immune responses that eliminate the virus.

Today on WebMD

Colorectal cancer cells
New! I AM Not Cancer Facebook Group
Lung cancer xray
See it in pictures, plus read the facts.
sauteed cherry tomatoes
Fight cancer one plate at a time.
Ovarian cancer illustration
Real Cancer Perspectives
Jennifer Goodman Linn self-portrait
what is your cancer risk
colorectal cancer treatment advances
breast cancer overview slideshow
prostate cancer overview
lung cancer overview slideshow
ovarian cancer overview slideshow
Actor Michael Douglas